173 related articles for article (PubMed ID: 23351869)
21. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model.
Mathavan N; Bosemark P; Isaksson H; Tägil M
Bone; 2013 Oct; 56(2):440-8. PubMed ID: 23845325
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective review.
Starman JS; Bosse MJ; Cates CA; Norton HJ
J Trauma Acute Care Surg; 2012 Mar; 72(3):676-81. PubMed ID: 22491552
[TBL] [Abstract][Full Text] [Related]
23. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products.
Kanakaris NK; Paliobeis C; Nlanidakis N; Giannoudis PV
Injury; 2007 May; 38 Suppl 2():S65-75. PubMed ID: 17920420
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic proteins in open fractures: past, present, and future.
Nauth A; Ristiniemi J; McKee MD; Schemitsch EH
Injury; 2009 Dec; 40 Suppl 3():S27-31. PubMed ID: 20082787
[TBL] [Abstract][Full Text] [Related]
25. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.
Calori GM; Tagliabue L; Gala L; d'Imporzano M; Peretti G; Albisetti W
Injury; 2008 Dec; 39(12):1391-402. PubMed ID: 19027898
[TBL] [Abstract][Full Text] [Related]
26. Autologous bone graft: when shall we add growth factors?
Giannoudis PV; Dinopoulos HT
Foot Ankle Clin; 2010 Dec; 15(4):597-609. PubMed ID: 21056859
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic proteins in critical-size bone defects: what are the options?
Schmidmaier G; Capanna R; Wildemann B; Beque T; Lowenberg D
Injury; 2009 Dec; 40 Suppl 3():S39-43. PubMed ID: 20082789
[TBL] [Abstract][Full Text] [Related]
28. Bone Morphogenic Protein for Upper Extremity Fractures: A Systematic Review.
Sandler AB; Scanaliato JP; Raiciulescu S; Nesti L; Dunn JC
Hand (N Y); 2023 Jan; 18(1):80-88. PubMed ID: 33789512
[TBL] [Abstract][Full Text] [Related]
29. Comparison of bone morphogenetic protein and autologous grafting in the treatment of limb long bone nonunion: a systematic review and meta-analysis.
Zhou YQ; Tu HL; Duan YJ; Chen X
J Orthop Surg Res; 2020 Jul; 15(1):288. PubMed ID: 32727538
[TBL] [Abstract][Full Text] [Related]
30. Growth factors: beyond bone morphogenetic proteins.
Nauth A; Giannoudis PV; Einhorn TA; Hankenson KD; Friedlaender GE; Li R; Schemitsch EH
J Orthop Trauma; 2010 Sep; 24(9):543-6. PubMed ID: 20736791
[TBL] [Abstract][Full Text] [Related]
31. Osteoinduction properties of different growth factors on cells from non-union patients: in vitro study for clinical application.
Gigante A; Cappella M; Manzotti S; Cecconi S; Greco F; Di Primio R; Mattioli-Belmonte M
J Biol Regul Homeost Agents; 2010; 24(1):51-62. PubMed ID: 20385071
[TBL] [Abstract][Full Text] [Related]
32. The bone morphogenic protein.
Derner R; Anderson AC
Clin Podiatr Med Surg; 2005 Oct; 22(4):607-18, vii. PubMed ID: 16213383
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients.
Ronga M; Baldo F; Zappalà G; Cherubino P;
Injury; 2006 Sep; 37 Suppl 3():S51-6. PubMed ID: 16952362
[TBL] [Abstract][Full Text] [Related]
34. Subtrochanteric fracture non-unions with implant failure managed with the "Diamond" concept.
Giannoudis PV; Ahmad MA; Mineo GV; Tosounidis TI; Calori GM; Kanakaris NK
Injury; 2013 Jan; 44 Suppl 1():S76-81. PubMed ID: 23351877
[TBL] [Abstract][Full Text] [Related]
35. BMPs: Options, indications, and effectiveness.
Giannoudis PV; Dinopoulos HT
J Orthop Trauma; 2010 Mar; 24 Suppl 1():S9-16. PubMed ID: 20182245
[TBL] [Abstract][Full Text] [Related]
36. BMP-2 but not VEGF or PDGF in fibrin matrix supports bone healing in a delayed-union rat model.
Kaipel M; Schützenberger S; Schultz A; Ferguson J; Slezak P; Morton TJ; Van Griensven M; Redl H
J Orthop Res; 2012 Oct; 30(10):1563-9. PubMed ID: 22508566
[TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic proteins: a powerful osteoinductive compound with non-negligible side effects and limitations.
Oryan A; Alidadi S; Moshiri A; Bigham-Sadegh A
Biofactors; 2014; 40(5):459-81. PubMed ID: 25283434
[TBL] [Abstract][Full Text] [Related]
38. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7.
Dahabreh Z; Dimitriou R; Giannoudis PV
Injury; 2007 Mar; 38(3):371-7. PubMed ID: 17070526
[TBL] [Abstract][Full Text] [Related]
39. The use of bone morphogenetic protein 7 in fracture non-unions.
O'hEireamhoin S; Quinlan JF; Rourke KO
Orthop Surg; 2011 Feb; 3(1):40-4. PubMed ID: 22009979
[TBL] [Abstract][Full Text] [Related]
40. External fixation of tibial pilon fractures and fracture healing.
Ristiniemi J
Acta Orthop Suppl; 2007 Jun; 78(326):3, 5-34. PubMed ID: 17465283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
